Definium Therapeutics, Inc. (DFTX) stock is being evaluated for further gains following a positive update from its Emerge trial.

A federal appeals court has rejected Sam Bankman-Fried's final attempt to overturn his conviction, affirming his 25-year prison sentence in one of the largest cryptocurrency fraud cases in history.

Bitcoin has experienced its worst week since the FTX crash, with its price plummeting due to a $1.72 billion weekly ETF exodus and institutional selloff. Analysts suggest further pain ahead, with a potential $1.75 trillion price shock on the horizon.

An analysis explores the implications of broad banking exposure versus megabank conviction, as reflected by the performance and holdings of banking ETFs KBE and FTXO.

An analysis compares investment strategies focusing on Main Street banking (IAT) versus Wall Street giants (FTXO) to help investors determine the better fit for their portfolios.

Law firm Fenwick has agreed to pay $54 million in a settlement related to its previous work for the now-bankrupt cryptocurrency exchange FTX.

Leading semiconductor ETFs, including SOXX, SMH, and FTXL, are performing exceptionally well, driven by strong demand for AI infrastructure.

Following the FTX collapse, institutional investors are increasingly reluctant to keep their cryptocurrency holdings on exchanges, opting for alternative storage solutions.

FTX is preparing to release $2.2 billion to its creditors, a move that is expected to have potential implications for the prices and market dynamics of cryptocurrencies like Bitcoin and XRP.

A financial comparison evaluates three technology-focused ETFs—XLK, VGT, and FTXL—to help investors determine which might be best suited for their portfolios.

Jefferies assigns a high probability of best-in-class efficacy for Definium Therapeutics' DT120, while Evercore notes Tremfya's market share gains for AbbVie but limited future earnings growth. Cognex's CFO sees improving demand, and analysts are bullish on AppLovin, Dave Inc., Chewy, and GoDaddy, despite Super Group facing a 'super simple short thesis'.

This article provides a comparative analysis of two major Consumer Staple Exchange Traded Funds, XLP and FTXG, examining their performance and investment characteristics.

Definium Therapeutics (DFTX) shares reached a new high following impressive trial results for its drug candidate, indicating positive progress in its clinical development.

Sam Bankman-Fried, the founder of FTX, has reportedly failed in his latest appeal attempt, indicating a setback in his legal proceedings.

An analysis compares First Trust's FTXG and iShares' IYK, evaluating which food and beverage focused ETF offers a better investment option for investors. The comparison delves into their respective strategies and potential returns.

Sam Bankman-Fried, the disgraced founder of the FTX cryptocurrency exchange, has reportedly sought a presidential pardon. He was convicted on fraud charges related to the collapse of FTX.

Despite having similar underlying holdings and fees, ETFs like FTXG vs. PBJ and SOXX vs. XSD have shown significantly different 5-year returns. This highlights how subtle differences in composition or weighting can lead to varied performance.

Fenwick, a law firm, has agreed to pay $54 million to settle claims made by customers of the collapsed cryptocurrency exchange FTX.

Patrick Gruhn, a former executive at the cryptocurrency exchange FTX, has stated that artificial intelligence has the potential to allow traders to generate profits without incurring any financial risk.

This article investigates and fact-checks the claim made by Sam Bankman-Fried (SBF) regarding the potential current valuation of FTX's assets, specifically whether they could be worth $114 billion today.

Nishad Singh, a former crypto engineer at FTX, has been fined $3.7 million by the CFTC but will avoid prison time for his involvement in the cryptocurrency exchange's collapse.

Definium Therapeutics Inc (DFTX) has announced that it possesses enough cash reserves to fund its operations well into 2028.

The chairman of HIVE Blockchain Technologies stated that the October cryptocurrency crash was significantly larger than the FTX collapse, highlighting the severity of the market downturn.

Nexo plans its US return after an SEC settlement, while a new report highlights cryptocurrency's increasing role in human trafficking networks.

A recent surge in SpaceX's valuation could potentially be worth billions for FTX, raising questions about whether the defunct crypto exchange's creditors will benefit.

An appeals court rejected arguments that Sam Bankman-Fried's trial was unfair and affirmed his 25-year prison sentence in one of the largest cryptocurrency fraud cases in history.

The U.S. government has moved $768,000 worth of seized FTX tokens, a development that has reportedly sparked fears of a potential Chainlink sell-off in the cryptocurrency market.

Former NBA player Udonis Haslem has reached a settlement in an FTX-related case, agreeing to pay $420,000, a significantly lower amount compared to Shaquille O'Neal's settlement.

Law firm Fenwick has agreed to pay $54 million in a settlement related to its previous work for the now-bankrupt cryptocurrency exchange FTX.

A former executive from the collapsed cryptocurrency exchange FTX has launched a new AI-powered trading platform, controversially claiming it offers 'no loss' trading.

FTX bankruptcy liquidators reportedly sold a stake in Cursor for $200,000, an asset that is now estimated to be worth billions. This highlights a significant missed opportunity in the bankruptcy proceedings.

Significant court dates are rapidly approaching in various cryptocurrency-related legal battles, including cases involving Roman Storm and former FTX CEO Sam Bankman-Fried.

Tether’s USDT Set for Biggest Monthly Retreat Since FTX Collapse  Bloomberg

Reports indicate that FTX creditors, particularly those holding Ethereum, might see a full recovery and potentially more than their initial investment due to the appreciation of crypto assets since the exchange's collapse.